Kiesgen, Stefan
Messinger, John C.
Chintala, Navin K. http://orcid.org/0000-0003-4229-0977
Tano, Zachary
Adusumilli, Prasad S. http://orcid.org/0000-0002-1699-2046
Article History
Received: 20 July 2020
Accepted: 19 November 2020
First Online: 15 February 2021
Competing interests
: P.S.A. has received research funding from ATARA Biotherapeutics and Acea Biosciences, has served on the Scientific Advisory Board or as consultant to ATARA Biotherapeutics, Bayer, Carisma Therapeutics, Imugene, and Takeda Therapeutics, and has patents, royalties, and intellectual property on mesothelin-targeted CARs and other T-cell therapies, and method for detection of cancer cells using virus, and pending patent applications on T-cell therapies.